| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 39.29B | 38.93B | 39.75B | 38.79B | 36.52B | 29.18B |
| Gross Profit | 10.32B | 10.00B | 10.14B | 10.09B | 10.63B | 8.39B |
| EBITDA | 3.08B | 3.56B | 2.70B | 1.91B | 3.18B | 3.49B |
| Net Income | 881.41M | 1.18B | 629.46M | 176.93M | 799.55M | 1.78B |
Balance Sheet | ||||||
| Total Assets | 19.71B | 21.53B | 19.95B | 21.10B | 19.58B | 17.61B |
| Cash, Cash Equivalents and Short-Term Investments | 7.22B | 7.13B | 7.59B | 6.90B | 6.50B | 5.24B |
| Total Debt | 5.39B | 5.67B | 5.25B | 7.13B | 5.13B | 5.59B |
| Total Liabilities | 10.45B | 11.57B | 10.69B | 12.25B | 10.11B | 10.04B |
| Stockholders Equity | 8.97B | 9.63B | 8.95B | 8.42B | 8.81B | 6.99B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.93B | 2.69B | 946.83M | 1.82B | 2.70B |
| Operating Cash Flow | 0.00 | 3.22B | 3.12B | 1.76B | 2.85B | 3.08B |
| Investing Cash Flow | 0.00 | -3.72B | -147.41M | -2.37B | -1.90B | -2.54B |
| Financing Cash Flow | 0.00 | -97.42M | -2.41B | 934.08M | 141.47M | -546.57M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥18.63B | 18.44 | ― | 0.90% | 12.34% | 2.41% | |
69 Neutral | ¥18.98B | 26.70 | ― | 2.13% | -5.40% | -37.51% | |
64 Neutral | ¥15.99B | 14.07 | ― | 2.36% | -2.06% | 87.60% | |
63 Neutral | ¥8.54B | 14.04 | ― | 0.95% | 10.61% | -1.13% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
60 Neutral | ¥20.39B | 9.79 | ― | 1.72% | 58.85% | 1630.07% | |
45 Neutral | ¥10.43B | -3.06 | ― | 5.03% | -6.49% | -402.49% |